GLP-1 receptor agonists can reverse immunosuppression-induced beta-cell dysfunction
It is well known that some of the agents commonly used during immunosuppressive (IS) therapy after solid organ transplantation can contribute to beta cell dysfunction and result in diabetes mellitus in the transplant recipient. Some of the risks associated with post-transplant diabetes mellitus (PTD...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2020-10-01
|
| Series: | CellR4 |
| Subjects: | |
| Online Access: | https://www.cellr4.org/wp-content/uploads/sites/2/2020/12/e2943.pdf |